BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 27677346)

  • 21. GRIM-19 associates with the serine protease HtrA2 for promoting cell death.
    Ma X; Kalakonda S; Srinivasula SM; Reddy SP; Platanias LC; Kalvakolanu DV
    Oncogene; 2007 Jul; 26(33):4842-9. PubMed ID: 17297443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thioredoxin reductase mediates cell death effects of the combination of beta interferon and retinoic acid.
    Hofmann ER; Boyanapalli M; Lindner DJ; Weihua X; Hassel BA; Jagus R; Gutierrez PL; Kalvakolanu DV
    Mol Cell Biol; 1998 Nov; 18(11):6493-504. PubMed ID: 9774665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GRIM-19, a death-regulatory gene product, suppresses Stat3 activity via functional interaction.
    Lufei C; Ma J; Huang G; Zhang T; Novotny-Diermayr V; Ong CT; Cao X
    EMBO J; 2003 Mar; 22(6):1325-35. PubMed ID: 12628925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mitochondrial GRIM-19 as a potential therapeutic target for STAT3-dependent carcinogenesis of gastric cancer.
    Huang Y; Yang M; Hu H; Zhao X; Bao L; Huang D; Song L; Li Y
    Oncotarget; 2016 Jul; 7(27):41404-41420. PubMed ID: 27167343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-derived mutations in the gene associated with retinoid interferon-induced mortality (GRIM-19) disrupt its anti-signal transducer and activator of transcription 3 (STAT3) activity and promote oncogenesis.
    Nallar SC; Kalakonda S; Lindner DJ; Lorenz RR; Lamarre E; Weihua X; Kalvakolanu DV
    J Biol Chem; 2013 Mar; 288(11):7930-7941. PubMed ID: 23386605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Verbascoside Inhibits Glioblastoma Cell Proliferation, Migration and Invasion While Promoting Apoptosis Through Upregulation of Protein Tyrosine Phosphatase SHP-1 and Inhibition of STAT3 Phosphorylation.
    Jia WQ; Wang ZT; Zou MM; Lin JH; Li YH; Zhang L; Xu RX
    Cell Physiol Biochem; 2018; 47(5):1871-1882. PubMed ID: 29961065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retinoid interferon-induced mortality19 (GRIM19) inhibits proliferation and invasion in rheumatoid arthritis fibroblast-like synoviocytes.
    Zhao D; Jiang Z; Wang Z; Gao J
    Biomed Pharmacother; 2018 Feb; 98():719-725. PubMed ID: 29306209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Down-regulation of GRIM-19 expression is associated with hyperactivation of STAT3-induced gene expression and tumor growth in human cervical cancers.
    Zhou Y; Li M; Wei Y; Feng D; Peng C; Weng H; Ma Y; Bao L; Nallar S; Kalakonda S; Xiao W; Kalvakolanu DV; Ling B
    J Interferon Cytokine Res; 2009 Oct; 29(10):695-703. PubMed ID: 19642906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GRIM-19 in Health and Disease.
    Máximo V; Lima J; Soares P; Silva A; Bento I; Sobrinho-Simões M
    Adv Anat Pathol; 2008 Jan; 15(1):46-53. PubMed ID: 18156812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GRIM-19 repressed hypoxia-induced invasion and EMT of colorectal cancer by repressing autophagy through inactivation of STAT3/HIF-1α signaling axis.
    Zhang J; Chu D; Kawamura T; Tanaka K; He S
    J Cell Physiol; 2019 Aug; 234(8):12800-12808. PubMed ID: 30537081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Curcumin-Mediated Apoptotic Cell Death in Papillary Thyroid Cancer and Cancer Stem-Like Cells through Targeting of the JAK/STAT3 Signaling Pathway.
    Khan AQ; Ahmed EI; Elareer N; Fathima H; Prabhu KS; Siveen KS; Kulinski M; Azizi F; Dermime S; Ahmad A; Steinhoff M; Uddin S
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and characterization of GRIM-1, a cell-death-associated gene product.
    Hofmann ER; Nallar SC; Lin L; D'Cunha J; Lindner DJ; Weihua X; Kalvakolanu DV
    J Cell Sci; 2010 Aug; 123(Pt 16):2781-91. PubMed ID: 20663920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic effects of signal transducer and activator of transcription 3 siRNA on human breast cancer in xenograft mice.
    Yang Z; Cai JH; Xie SJ; Li GX; Song WQ; Yan QH; Yan L; Zhang F
    Chin Med J (Engl); 2011 Jun; 124(12):1854-61. PubMed ID: 21740845
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Cao F; Zhang Q; Chen W; Zheng F; Ran Q; He Y; Gao Y; Yao S
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29074558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GRIM-19 mutations fail to inhibit v-Src-induced oncogenesis.
    Kalakonda S; Nallar SC; Lindner DJ; Sun P; Lorenz RR; Lamarre E; Reddy SP; Kalvakolanu DV
    Oncogene; 2014 Jun; 33(24):3195-204. PubMed ID: 23851499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Convallatoxin promotes apoptosis and inhibits proliferation and angiogenesis through crosstalk between JAK2/STAT3 (T705) and mTOR/STAT3 (S727) signaling pathways in colorectal cancer.
    Zhang ZH; Li MY; Wang Z; Zuo HX; Wang JY; Xing Y; Jin C; Xu G; Piao L; Piao H; Ma J; Jin X
    Phytomedicine; 2020 Mar; 68():153172. PubMed ID: 32004989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Correlations of GRIM-19 and its target gene product STAT3 to malignancy of human colorectal carcinoma].
    Gong LB; Luo XL; Liu SY; Tao DD; Gong JP; Hu JB
    Ai Zheng; 2007 Jul; 26(7):683-7. PubMed ID: 17626740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasmid-based Survivin shRNA and GRIM-19 carried by attenuated Salmonella suppresses tumor cell growth.
    Liu YB; Zhang L; Guo YX; Gao LF; Liu XC; Zhao LJ; Guo BF; Zhao LJ; Zhao XJ; Xu DQ
    Asian J Androl; 2012 Jul; 14(4):536-45. PubMed ID: 22580637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a structural motif in the tumor-suppressive protein GRIM-19 required for its antitumor activity.
    Nallar SC; Kalakonda S; Sun P; Ohmori Y; Hiroi M; Mori K; Lindner DJ; Kalvakolanu DV
    Am J Pathol; 2010 Aug; 177(2):896-907. PubMed ID: 20595633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of monocarbonyl curcumin-BTP hybrids as STAT3 inhibitors for drug-sensitive and drug-resistant breast cancer therapy.
    Zhang W; Guo J; Li S; Ma T; Xu D; Han C; Liu F; Yu W; Kong L
    Sci Rep; 2017 Apr; 7():46352. PubMed ID: 28397855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.